FibroGen's market cap is currently ―. The company's EPS TTM is $-2.925; its P/E ratio is -0.45; FibroGen is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 27.14M	$ 40.13M	$ 23.89M	$ 24.16M	$ 34.37M
Gross Profit	$ 21.73M	$ 35.89M	$ 44.32M	$ 32.67M	$ 29.44M
EBIT	$ -55.19M	$ -59.19M	$ -79.69M	$ -75.06M	$ -72.83M
EBITDA	$ -54.74M	$ -58.65M	$ -78.10M	$ -72.78M	$ -70.38M
Net Income Common Stockholders	$ -48.25M	$ -67.91M	$ -87.68M	$ -77.74M	$ -59.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 235.59M	$ 251.34M	$ 335.72M	$ 355.95M	$ 422.01M
Total Assets	$ 423.53M	$ 460.43M	$ 515.13M	$ 538.54M	$ 610.09M
Total Debt	$ 152.55M	$ 153.59M	$ 156.23M	$ 86.81M	$ 89.89M
Net Debt	$ -83.04M	$ -97.75M	$ -179.48M	$ -269.14M	$ -332.12M
Total Liabilities	$ 585.73M	$ 575.63M	$ 575.43M	$ 567.43M	$ 611.57M
Stockholders Equity	$ -204.17M	$ -157.17M	$ -102.27M	$ -48.85M	$ -21.45M
Cash Flow	-
Free Cash Flow	$ -18.57M	$ -85.22M	$ -111.56M	$ -102.18M	$ -52.85M
Operating Cash Flow	$ -18.32M	$ -84.54M	$ -110.57M	$ -101.59M	$ -52.51M
Investing Cash Flow	$ 10.24M	$ 54.22M	$ -14.29M	$ 103.48M	$ 1.09M
Financing Cash Flow	$ -246.00K	$ -22.00K	$ 91.53M	$ 31.48M	$ 48.67M

Currency in USD

FibroGen Earnings and Revenue History

Income Statement >

FibroGen Debt to Assets

Balance Sheet >

FibroGen Cash Flow

Cash Flow >

FibroGen Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing